Carlsbad, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a company that designs and manufactures innovative medical devices that improve spinal surgery outcomes, announced today that it is the recipient of the 2022 Spine Technology of the Year Awarded for DEXA Technology™ bone density matched intervertebral implants.
Aurora’s DEXA technology is licensed by RRY Publications LLC and Orthopedics of the Week Magazine’s innovative technology designed to match spinal implants to a patient’s bone density. The award will be presented at the 37th North American Spine Society (NASS) Annual Meeting in Chicago, USA.
Aurora Spine’s first-of-its-kind DEXA Technology™ is designed to match a patient’s bone density and promote bone ingrowth while maintaining biomechanical structure and bone support. This innovative concept is being used to create implants that are matched to patient-specific bone density based on DEXA scans/T-scores, resulting in optimal fusion therapy and the most favorable outcomes.
Aurora Spine’s DEXA Technology™ is part of the company’s advanced product portfolio and represents the future of spinal and orthopaedic implants. Following the fundamental principles of patent-focused innovation, DEXA Technology™ was created and patented to logically combine the fundamental design advantages of conventional machining, 3D printing and additive implant manufacturing.
Trent Northcutt said, “We are honored to receive this prestigious award and the recognition of our work by the orthopaedic industry because our DEXA Technology™ is the world’s only innovative technology that provides surgeons with additional solutions to help them choose the right implant for the patient,” Aurora Spine CEO.
Laszlo Garamszegi, CTO of Aurora Spine, added: “We thank you Orthopedics of the Week The distinguished panel of spine surgeons for the 2022 Best New Spine Technology Award and their consideration of Aurora’s DEXA technology is a huge recognition of the hard work and dedication of our team and our physician partners. “
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant market through a range of innovative, minimally invasive, regenerative spinal implant technologies.
Neither the TSX Venture Exchange nor its Regulatory Services Provider (as that term is defined in TSX Venture Exchange’s policies) accepts responsibility for the adequacy or accuracy of this press release.
forward-looking statements
This press release contains forward-looking information that involves a number of known and unknown risks and uncertainties, most of which are beyond Aurora Spine’s control, including, but not limited to, those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information” information” in Aurora Spine’s final prospectus (collectively, the “forward-looking information”). The forward-looking information in this press release includes information regarding the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions Aurora Spine Investors in the securities are aware of important factors that could cause Aurora Spine’s actual results to differ materially from those projected in any forward-looking statements contained in this press release. Any expressions or references to expectations, beliefs, plans, objectives, assumptions or future None of the statements in the discussion of events or performance are historical facts, may be forward-looking, and may involve estimates, assumptions and uncertainties that could cause actual results or results to unilaterally differ from those expressed in such forward-looking statements. The expectations set forth herein will prove to be correct and, therefore, potential investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release, and Aurora Spine undertakes no obligation to update or revise them to reflect obligations for new events or circumstances.
touch:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Claus
CFO
(760) 424-2004
www.aurora-spine.com
Adam Lowensteiner
Latham Partners LLC
Phoenix | New York
Phone: 646-829-9700
arosf@lythampartners.com
